Tiny trial hopes fatty acid oil boosts preterm baby development
NCT ID NCT07311382
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving very preterm babies (born before 32 weeks) a special oil containing arachidonic acid and DHA helps them absorb these essential fatty acids. Fifteen babies will receive the supplement from their first days of life until 36 weeks or discharge. Researchers will measure fatty acid levels in blood and also look at effects on brain function, lung development, and growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- oil containing arachidonic acid and docosahexaenoic acid (DHA)
- What this could lead to
- If it works, this could point toward a way to improve brain and lung development in very preterm babies by giving them essential fatty acids early.
- What could go wrong
- This is a very small early study with only 15 babies, so results may not apply to all preterm infants. It is designed to measure absorption, not to prove health benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CONCENTRATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
La Paz Hospital
Madrid, 28046, Spain